Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$GTCH 8K out: GTX Agreement On April 12, 2022, GBT Tokenize Corp (“Tokenize”), a Nevada corporation which GBT Technologies, Inc. (the “Company”) owns 50% of the outstanding shares of common stock, entered into a series of agreements with GTX Corp (“GTX”) and various note holders of GTX pursuant to which Tokenize acquire convertible promissory notes of GTX in the principal amount of $100,000 (the “GTX Notes”). In addition, Tokenize acquired 5,000,000 shares of common stock of GTX for a purchase price of $150,000.
The GTX Notes bear 10% interest per annum and 50% of the principal may be converted into shares of common stock on a one-time basis at a conversion price of $0.01 per share. The remaining 50% of the principal must be paid in cash.
The closing occurred on April 12, 2022.
Magic Agreement
The Company, through its wholly owned subsidiary, Greenwich International Holdings, a Costa Rica corporation (“Greenwich”), entered into a Master Joint Venture and Territorial License Agreement (the “Tokenize Agreement”) with Magic Internacional Argentina FC, S.L. (“Magic”) and Tokenize which replaced a prior joint venture entered between the parties.
The purpose of Tokenize is to develop, maintain and support source codes for its proprietary technologies including advanced mobile chip technologies, tracking, radio technologies, AI core engine, electronic design automation, mesh, games, data storage, networking, IT services, business process outsourcing development services, customer service, technical support and quality assurance for business, customizable and dedicated inbound and outbound calls solutions, as well as digital communications processing for enterprises and startups (“Technology Portfolio”), throughout the world, which Technology Portfolio was previously licensed to the Company for the State of California.
The Tokenize Agreement provides that the Company shall contribute 150,000,000 shares of common stock of the Company (“GBT Shares”) to Tokenize. Sergio Fridman is the manager of Magic and the beneficial owner of all outstanding securities of Magic. Magic will contribute cash of $250,000 into Tokenize in consideration of a promissory note and agreed to further fund Tokenize with all funds reasonably needed for implementation of the business purposes as described in the Tokenize Agreement. The GBT Shares will not be transferable for a period of five years.
Magic and the Company each own 50% of the outstanding shares of common stock of Tokenize. The Company pledged its 50% ownership in Tokenize and its 100% ownership of Greenwich (the “Pledged Securities”) to Magic for providing that Magic may take possession of such Pledged Securities in the event the Company executes, delivers and performs any future agreement or document or judgement resulting in the creation of any lien, pledge, mortgage, claim, charge or encumbrance upon any assets of the Company. The Company shall appoint two directors and Magic shall appoint one director of Tokenize.
The offer, sale and issuance of the above securities was made to an accredited investor and the Company relied upon the exemptions contained in Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506 of Regulation D promulgated there under with regard to the sale. No advertising or general solicitation was employed in offering the securities. The offer and sales were made to an accredited investor and transfer of the common stock will be restricted by the Company in accordance with the requirements of the Securities Act of 1933, as amended.
The foregoing descriptions of the terms of the above transactions do not purport to be complete and are qualified in their entirety by reference to the provisions of such agreements, the forms of which are filed as exhibits to this Current Report on Form 8-K.
$YUKA Yuka Group Inc (PK) (YUKA)
0.48 + 0.11 (29.73%)
$QUAN Check out their updates on facebook Quantum%20International%20Corp" rel="nofollow noopener noreferrer ugc" target="_blank">Quantum%20International%20Corp" rel="nofollow noopener noreferrer ugc" target="_blank">https://www.facebook.com/search/top/?q=Quantum%20International%20Corp
$QUAN Filed Annual Report: https://www.otcmarkets.com/otcapi/company/financial-report/323430/content
$QUAN Although blockchain has come a long way, it is still very early in its development and the blockchain is not user friendly for the non-tech savvy.
$QUAN Quantum International Corp. (QUAN) Provides Corporate Updates and Election of New Board Members
quantum-international-corp-quan-provides-corporate-updates-and-election-of-new-board-members" rel="nofollow noopener noreferrer ugc" target="_blank">quantum-international-corp-quan-provides-corporate-updates-and-election-of-new-board-members" rel="nofollow noopener noreferrer ugc" target="_blank">quantum-international-corp-quan-provides-corporate-updates-and-election-of-new-board-members" rel="nofollow noopener noreferrer ugc" target="_blank">quantum-international-corp-quan-provides-corporate-updates-and-election-of-new-board-members" rel="nofollow noopener noreferrer ugc" target="_blank">https://www.bloomberg.com/press-releases/2022-03-07/quantum-international-corp-quan-provides-corporate-updates-and-election-of-new-board-members
$QUAN RECENT NEWS! #Pink Current Quantum International Corp (QUAN: Pink Current) | Quantum International Corp. (QUAN) Provides Updates on the LootUp App and Features
https://finance.yahoo.com/news/quantum-international-corp-quan-provides-110700262.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
$QUAN Some DD here https://www.marketwatch.com/investing/stock/quan/charts?mod=mw_quote_tab
$NICH..Bringing steady dollars to the bottom line!>>>>>>>$NICH to Develop Exclusive Clothing Line with Legendary Football Coach Steve Calhoun and His Armed and Dangerous Training Camp
https://www.otcmarkets.com/stock/NICH/news/Nitches-to-Develop-Exclusive-Clothing-Line-with-Legendary-Football-Coach-Steve-Calhoun-and-His-Armed-and-Dangerous-
$TPIA Mental illness is a complex problem that requires individualized treatment. What works for one person might not work for another. This means that we need to come up with a variety of different treatments and therapies.
https://www.l3opptrk.com/3J67C1/3G4SGXC/
$TPIA Despite the Outdated Bad Press, Psych-e-delic-Assisted Psychotherapy is an Incredibly Valuable Innovation.
https://www.l3opptrk.com/3J67C1/3G4SGXC/
$TPIA Consider TPIA if you’re looking for an exciting and promising add to your portfolio
https://www.l3opptrk.com/3J67C1/3G4SGXC/
$TPIA is Poised Above All the Rest to Potentially Capitalize on this Growth Filled Market https://biotechresearchreport.com/new-unconventional-medical-treatment-could-be-unusually-lucrative/?utm_source=bullzeyemedia&utm_medium=affiliate&utm_campaign=tpiaz_us&_ef_transaction_id=4616c2cf5cf84fd8b19c1e3c257e6ad4
$SNPW: Advanced Solar Power Tech and Green Waste Recovery Plants: Sun Pacific Holding Company (OTC: SNPW)
Click here:
https://www.einnews.com/amp/pr_news/567600872/advanced-solar-power-tech-and-green-waste-recovery-plants-sun-pacific-holding-company-otc-snpw
About Sun Pacific Holding Corp.
Sun Pacific Holding Corp. (Other OTC: SNPW) uses management's knowledge and experience to serve its customers and now its shareholders through quality service and equipment, working to keep customers satisfied, and by doing our part in protecting the environment with smart green technology. For more information, visit http://www.sunpacificholding.com
$QUAN Filed Annual Report: https://www.otcmarkets.com/otcapi/company/financial-report/323430/content
$TPIA Nice info here https://www.l3opptrk.com/3J67C1/3G4SGXC/
$QUAN 100% BUY Barchart Opinion! https://www.barchart.com/stocks/quotes/QUAN/opinion
$TPIA Mental illness is a complex problem that requires individualized treatment. What works for one person might not work for another. This means that we need to come up with a variety of different treatments and therapies.
https://www.l3opptrk.com/3J67C1/3G4SGXC/
$QUAN Welcome to a New Era of Decentralized Payments. LootUp, a Non-Custodial P2P Payment Platform, aims to become the first globally adopted decentralized payment platform that is self-regulated and which is backed by a digital asset.
$WKSP Worksport Ltd (WKSP)
3.05 + 0.19 (6.64%)
Volume: 94,473 @04/05/22 10:44:59 AM EDT
$NICH..There was a fire on the internet a couple of days ago!>>>>> https://microcapdaily.com/nitches-inc-otcmkts-nich-heating-up-getting-noticed-as-co-reduces-os-by-80-and-launches-nitches-ovs-its-new-owner-verification-system-ovs-mobile-app/
$WKSP In the month since Russia’s invasion of Ukraine began on Feb 24, 2022, the WKSP stock soared 18.13% from $1.93 on the day of the invasion to its Mar 23, 2022 close of $2.28.
$GTCH “We extended our active registration with SAM which means we are approved to conduct business with US government agencies, local municipals, cities, states, contractors and suppliers. GBT has extensive knowledge and experience in advanced technological arenas, among them IoT, database security, tracking, health, artificial intelligence, and integrated circuits. We believe that the current government push to move high tech industries such as microchip design and manufacturing back to America will open R&D and sales opportunities for the company. By using our technologies and offering efficient solutions for military, global emergency response, security, microchip manufacturing, global health, along with design intelligent image/video processing. We will continue to pursue our 2021 strategy through offering essential technology solutions to governments and large technology companies,” stated Mansour Khatib, GBT’s CEO.
https://www.marketwatch.com/press-release/gbt-extended---system-award-management-sam-until-may-2023-2022-02-22?
$GTCH The Infinia System design contemplates communication through ionospheric propagation environment with the goal of reaching long distances, creating a private, secured radio frequency (RF) network.
The main aim of the application-specific, cybersecurity technology is to create secured level communications with the goal of serving military and governmental applications. The Infinia System is being developed with the goal of using a few types of encryptions/decryptions techniques, including authentication/authorization measures to ensure robust wireless network protection.
The technology’s AI algorithms will automatically apply the best encryption/decryption technique according to application type, weather/terrain conditions and priorities. The Infinia System contemplates the incorporation of a deep learning module that will periodically change the exchanged keys to prevent a network interception, maintaining data integrity and real-time error correction. The techniques include implementation of symmetric and asymmetric encryption methodologies according to the network’s characteristics and nature. When fully implemented, it is believed that the system’s main advantage will be its analytics-based reasoning capabilities to elect the best cryptographic method to ensure robust security.
When fully developed, GBT intends to target the Infinia System for use by civil and military long range communication applications including, among them emergency response, remote telemedicine and worldwide rescue. GBT intends to file a comprehensive non-provisional patent for the system during the next few months.
"We are now working on proprietary data protection and secured communication cryptographic methodologies. Wireless systems suffer from serious security vulnerabilities especially when used in military and governmental applications. Data can be exposed to intruders’ attacks, theft and jamming. We believe our advanced cryptographic methods, upon development, will provide a cognitive cybersecurity system ensuring its reliability and security.
The AI governed system is intended to make real time intelligent decisions regarding the use of symmetric or asymmetric encryption methods according to the application nature, weather and terrain conditions. For example, an emergency communication will be automatically using a symmetric encryption technique due to its high-speed response requirements with the goal of rushing rescue teams to the site. In case of an operation requiring confidentiality, an asymmetric encryption method will be used to ensure an extra level of security. As asymmetric encryption sacrifices speed due to key’s length. Accordingly, a symmetric encryption may be the right choice to enable faster response.
Our comprehensive cybersecurity solution is being designed to include adaptive capabilities to address various communication perspectives. The system is targeting to manage the RF communication security dynamically and will quantify the network’s radio devices, identify unauthorized intruders and supervise encryption/decryption operations. We intend to incorporate a real time response that will be made in case of a security breach detection by isolating nodes, changing RF characteristics, encryption keys change and additional steps. We intend to incorporate a deep learning module that will continuously monitor Infinia’s communication channel characteristics ensuring vigorous security. A highly secured, reliable, global communication is the main aim for the Infinia System and a comprehensive cybersecurity technology is a must have, especially for military and governmental applications“ stated Danny Rittman, the Company’s CTO.
$VMHG Interactive Chart VMHG/interactive-chart" rel="nofollow noopener noreferrer ugc" target="_blank">VMHG/interactive-chart" rel="nofollow noopener noreferrer ugc" target="_blank">VMHG/interactive-chart" rel="nofollow noopener noreferrer ugc" target="_blank">VMHG/interactive-chart" rel="nofollow noopener noreferrer ugc" target="_blank">https://www.barchart.com/stocks/quotes/VMHG/interactive-chart
$VMHG Technical Analysis VMHG/technical-analysis" rel="nofollow noopener noreferrer ugc" target="_blank">VMHG/technical-analysis" rel="nofollow noopener noreferrer ugc" target="_blank">https://www.barchart.com/stocks/quotes/VMHG/technical-analysis
$SOFSF Profile and Stock Chart Analysis
$WKSP Folow on Twitter for updates
https://twitter.com/WorksportLtd
$WKSP Mississauga, March 31, 2022 (GLOBE NEWSWIRE) -- Worksport Ltd. (Nasdaq: WKSP) (the “Company”) has contracted leading manufacturers’ representative firm, N.A. Williams Company, for category management setup of and operations, analysis, and reporting for eCommerce marketplaces including the Company’s native platform, Amazon, eBay, and mass retail through Walmart, with NewEgg and Sears integrations at the Company’s discretion. Serving national accounts, including, but not limited to, Advance Auto Parts, AutoZone, Costco, and Home Depot, N.A. Williams is well-equipped with industry professionals to manage an original equipment manufacturer such as Worksport.
$EHVVF: Ehave Continues Expansion Of KetaDASH Mobile Psychedelic Service By Providing Licensed Psychotherapists And Registered Nurses
March 3, 2022 (Globe Newswire)
-- Agreement with Heally adds doctors, licensed psychotherapists and registered nurses to the KetaDASH platform
-- With the opening of KetaDASH, Ehave builds momentum for the psychedelic renaissance in the mental health field
-- Both the KetaDASH patient and nurse connect to a psychotherapist via Heally's telehealth portal for each treatment session
Ehave, Inc. (OTC Pink: EHVVF) (the "Company"), a leading healthcare services and technology company, announced today it will partner with Heally, the all-in-one platform and electronic medical record (EMR)/telehealth solution for alternative medicine providers, to provide Licensed Psychotherapists And Registered Nurses to its KetaDASH patients. This mobile solution departs from in-person intravenous treatment, as well as unsupervised telehealth models.
Heally created a platform designed to help alternative medicine clinics address the needs of patients regardless of their location. The platform provides a telehealth and EMR software solution, while concurrently managing lead generation, patient engagement and access to an ecosystem of hundreds of thousands of patients and providers. Ketamine provides an alternative medicine option for those with treatment-resistant depression, post-traumatic stress disorders (PTSD), anxiety, and other mental health conditions. Through the use of Heally's platform, a registered nurse arrives at the patient's preferred location -- be it home, office, or hotel -- and safely administers a sublingual ketamine lozenge. Together, the patient and nurse, connect to a psychotherapist via Heally's telehealth portal to begin each treatment session.
"Heally is the perfect platform to help expand the reach of alternative medicine clinics specifically in the psychedelic treatment space," said Heally CEO Greg Rovner. "Our software solutions provide all the necessary tools alternative medicine clinics need to manage their practice and treat patients online."
Ehave's KetaDASH service provides patients with an in-home setting that offers a space for healing, growth and transformation through psychedelic therapies. Mental health continues to be a national health crisis as rates of anxiety, depression and PTSD keep climbing. The Covid-19 pandemic has impacted the quality of care, access to healthcare providers, and driven a greater demand for mental health professionals than ever before. The World Health Organization says depression is one of the leading causes of disability. Suicide is the second leading cause of death among 15-29-year-olds. People with severe mental health conditions die prematurely - as much as two decades early - due to preventable physical conditions. More than 47 million American workers quit their jobs in 2021, according to the U.S. Bureau of Labor Statistics. 84% of employees reported at least one workplace factor that negatively impacted their mental health, while 50% of employees claimed to leave their jobs for their mental health in 2021.
Ben Kaplan, CEO of Ehave, said, "KetaDASH provides us with the transformative power of our psychedelic-assisted therapy protocols for people struggling with their mental health. KetaDASH is a managed service organization focused on the psychedelic sector that benefits physicians by helping them streamline their practice operations, create new revenue opportunities, and achieve better patient outcomes." Mr. Kaplan continued, "As we continue to grow into new markets, the potential to positively change people's lives is endless. Access to Heally's platform along with its provider network of licensed doctors, psychotherapists, and registered nurses will allow us to expand to those new markets quicker, while offering alternative treatment to those who need it."
About Ehave, Inc.
Ehave is a leading healthcare services and technology company, focused on progressing psychedelics-to-Therapeutics by engineering novel compounds and new treatment protocols for treating brain health. Together with our network of scientists and mental health professionals, we are on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues, leveraging clinical data to help us achieve optimal patient outcomes. Ehave's operations span across the entire USA, Canada, Jamaica, and Australia. Additional information on Ehave can be found on the Company's website at: www.ehave.com
About Heally
Heally is the only all-in-one platform and EMR/telehealth solution for alternative medicine clinics. Heally brings alternative medicine clinics online and connects patients to licensed physicians in-office or online via telehealth, leveraging HIPAA-compliant encrypted live video and messaging. https://getheally.com
Forward-Looking Statement Disclaimer
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company's research, manufacturing and other development efforts; (ii) the Company's ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company's products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company's industry and introduction of competing products; (vi) the Company's ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is contained under the heading "Risk Factors" in Ehave, Inc.'s Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC) on September 24, 2015, as amended, which is available on the SEC's website, http://www.sec.gov.
For Media and Investor Relations, please contact:
David L. Kugelman
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
Email: Ir@Ehave.com
Skype: kugsusa
LinkedIn: https://www.linkedin.com/in/davidkugelman
$GTCH SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) is concluding its qTerm vitals device with temperature measurement enhanced algorithms, with the goal further improving its accuracy and feedback. The code enhancements were made within high system’s level to advance the finger, device, and ambient temperature interactions and reporting. Testing was conducted to finalize qTerm GEN III prototype device and based on the collected data, GBT has finalized the device’s functionality and features. qTerm, a human vitals intelligent device is targeted to measure human vitals with a touch of a finger. The device includes sensors for oxygen (SPO2), heart rate and IR (Infra-Red) type for body temperature, including a coprocessor microchip that provides advanced calibration algorithm to assist users with qTerm’s usage. The device is accompanied by a smartphone app and a synchronized web widget to keep a history and provide health analytics. The widget enables the user to view qTerm’s results worldwide, making it an efficient remote telemedicine technology. The device is planned to use GBT’s AI technology for ongoing vitals’ data recordation, analytics, and health monitoring. In case of abnormalities the system will alert, advising further health related steps. The system will be offering API (Application Programming Interface) capabilities to be connected to hospitals and clinics health system, enabling health professional to view patient’s history and analytics. GEN III prototype has gone through enclosure, circuit, and software modifications to attain a stable and accurate results, targeting personal and clinics usage.
https://www.nasdaq.com/press-release/gbt-is-concluding-its-qterm-vitals-device-with-temperature-measurement-algorithms
$GTCH GBT Is Concluding Its qTerm Vitals Device With Temperature Measurement Algorithms Enhancements
https://finance.yahoo.com/news/gbt-concluding-qterm-vitals-device-120000298.html
$NICH..Grab em down here while you can!>>>>>Apple just approved our most recent update to the NitchesOVS app in the AppStore. We expect the Google App to be approved soon for the PlayStore. More Updates coming this week.
$NICH
#AppStore #Merch #web3 #polygonmatic #celebrity #influencer
$VMHG Victory Yachts is one of the leading sellers of luxury vessels in the world. With the economy growing, consumer trust increases and the luxury yacht industry continues to grow in leaps and bounds. Meanwhile, advancements in technology and engineering have created stunning new vessels like never before. The offshore environment is now catering to the wealthiest individuals in the world, with the attraction and freedom of a luxurious, yacht centric life on the water.
https://victorymarineholdings.com/
$GTCH "We believe our Apollo concept may have applications in several domains, among them are health, smart vehicles, security and more. With this in mind, we filed a continuation application with the goal of further broadening and expanding the protection of the technology. The Apollo patent seeks to protects the concept of an AI controlled radio technology to achieve accurate “visibility” capabilities through walls and other mediums. The goal of the technology is designed to enable rapid analysis of RF data using neural networks, identifying living and stationary entities and constructing their computerized imaging. We intend to also explore more efficient implementations of this technology including observing alertness of a driver, intruder detection and facial recognition. We plan to further research into the development of intelligent systems based on these concepts.” Said Danny Rittman, the Company’s CTO.
https://www.marketwatch.com/press-release/gbt-filed-continuation-application-for-its-wireless-motion-detection-and-imaging-technology-2022-03-29?mod=mw_quote_news_seemore
$AXXA: Exxe Group to Reduce Debt, Adjust Future Share Count, Enhancing Shareholder Value
Exxe is strengthening its balance sheet by reducing aged debt and potential share count,
Estimated up to $20M of early 2022 maturity liabilities to be reduced, eliminated, converted,
Exxe's equity set to increase via debt reduction and favorable balance sheet amendments,
Capital structure changes include limited stock issuance for the quarter ending June 30, 2022
Exxe seeks to capitalize on greater investment opportunities via an improved balance sheet
NEW YORK, NY / ACCESSWIRE / March 9, 2022 / Exxe Group, Inc. (OTC PINK:AXXA), ("Exxe" or the "Company") diversified private equity, real estate, and fintech company is pleased to announce that it is in the process of strengthening its balance sheet by reducing, eliminating, or adjusting aged debt, thereby increasing equity and shareholder value, along with lessening potential future share count.
Management has identified up to $20 million of aged debt carrying the first half of 2022 maturities that shall be amended via conversion into restricted preferred equity, or into debt with maturities to extend additional 36 months. In conjunction with the balance sheet enhancements, Exxe plans to limit stock issuances during June 2022 quarter. These steps are designed to serve as a positive for the Company and its investors. First, debt reduction and simultaneous equity conversion should translate into a greater equity value and reduced liabilities. Second, completing a limited stock issuance in one transaction should reduce potential multiple additions to the share count and increase confidence in the overall business model.
As with the debt settlement, Exxe Group's objective is to eliminate up to $4M of accrued interest and long-term debt. Up to $8M or nearly 10% of total outstanding debt is planned to be converted to restricted preferred equity while only a limited issuance is planned in the June 2022 draft period representing less than 1% of total debts. This event will reduce potential, future share overhangs versus the completion of multiple transactions during the period. Exxe believes that this restructuring of debt will put Exxe in a stronger capital structure, potentially opening up greater private equity and real estate acquisition opportunities.
Exxe businesses that are targeted for debt recapitalizations or asset reallocations include Hemp and Agribusiness provider Flying Creek division(FCD), energy products provider Lucent Led Tech(LLT), AXXA Digital Communities(ADC), as well as AXXA Autoparts, M MOTO division(AMD). In the coming weeks, management will finalize specific changes for these businesses and possibly other Exxe related divisions. These changes include varying percentages of debt reduction and the remainder converting into restricted preferred equity. The remaining current debt portion terms shall be lengthened into future maturity dates.
Dr. Eduard Nazmiev, Exxe Group CEO, commented on the debt restructure and its potential impact on the Company. "At Exxe Group, our leadership team is always seeking methods to enhance shareholder value. We have listened to shareholders and advisors who have suggested ways to improve our capital structure and leverage potential, future acquisition opportunities. By reducing and converting aged liabilities with early 2022 maturities, and completing limited equity issuance in the coming months, we accomplish key objectives. Exxe enhances shareholder value and does so with limited stock issuance during the quarter ending on June 30, 2022. The changes we outlined in this release should position the Company to capitalize on new, greater opportunities while improving our debt and shareholder equity positions."
About Exxe Group
Exxe Group is a diversified fintech corporation focusing on acquisitions in the following sectors: real estate, sustainable technology, media, agribusiness, and financial services. Exxe Group is an acquisition-driven company. The Company strategy is to acquire controlling equity interests in undervalued companies and undertake an active role in improving their performance - accelerating their growth by providing both access to capital and management expertise.
For additional information please visit the Company's
Website: http://www.exxegroup.com/
Twitter: https://twitter.com/exxegroup
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release.
CONTACT: Exxe Group IR: info@exxegroup.com
Image: https://www.accesswire.com/users/newswire/images/692258/vZsENh_RFkDRxOjFhOIX4n_OlWLipBRuGnBT5IgMQmPUe2X9DhTuqkZbNfH-3gfxStOHwGPtwN-QSxIiBEt5a-L8j0MT2z6gTvS6IKnkLgm3H_qhJ_OMWJ_VlMfbOFDPmqBZdtqE.jpgImage: https://www.accesswire.com/users/newswire/images/692258/WhsdkdB1UJshM0ZDBz5ULEu3qxWIangQAo1cuA3_JQ_YUC4wblPFwwKaniIFmUyS-1MMwCaPHDSmiEpumdVHtqBcib9matT0zLBaqfaFnHYdHhxsiiqKPvw_Y7AhQCmdGyDzsoIS.jpg
SOURCE: Exxe Group
View source version on accesswire.com:
https://www.accesswire.com/692258/Exxe-Group-to-Reduce-Debt-Adjust-Future-Share-Count-Enhancing-Shareholder-Value
$KOSK The company targets the vending industry to offer innovative CBD products and create a network of co-operative businesses.
$MGON News: Megola Confirms 2 Acquisition Product Lines
Acquires Specialty Coffee Product Line
Acquires Sio2 Proteksol for Seed & Foliage Coating
Larger deals forthcoming
BONITA SPRINGS, FL / ACCESSWIRE / March 14, 2022 / Megola Inc. (OTC PINK:MGON) Megola, Inc. ("MGON", "Company") is a Consortium Group of Health Technologies and Eco-Friendly Product Lines. Megola through product and technology acquisitions has grown to have its own E-commerce Branding Division, Service Department, Licensing Division, Franchise Division all maintaining Megola's diverse manufactured product portfolios. "These are just the start of our acquisitions as the company is in the final stages of negotiations for several other product line offerings from Medesol LLC and others," states CEO Robert Gardiner. ‘We will start to offer our coffee lines on our eCommerce site along with other distribution networks and we will start a pilot project with a large Canadian marijuana grower for the Proteksol Seed coating shortly", continues Gardiner.
On February 22, 2022, MGON entered into a Purchase and Sale of Business Assets Contract with RBG Wholesale, in which MGON has agreed to purchase certain Specialty Coffee product lines, branding label and supply agreements, for the purchase price of Fifteen Thousand Dollars ($15,000), payable as follows: (1) fifteen thousand (15,000) shares of MGON Series F Preferred Stock, valued at $1.00 per share.
PRODUCT LINES:
Health and Wellness coffee
* Weight Loss Coffee - increases metabolism through a thermogenic boost helping to burn calories and convert fatty acids and glucose into energy inhibiting the production of fat tissue and increasing energy. Infused with Hoodia Gordoni and Garcinia Chromium Picolinate
* Immune Boost Coffee - enhances overall vitality, immune and nervous system, increases antibody production, helps restore health and fight bacteria, boost polysaccharides and polyphenols. Infused with Black Samson Echinacea, Chinese Astralagus, Reich, and Chealated Zinc.
* Sensuality Tonic Blend - increases libido in both women and men, helps sustain balanced levels of progesterone and testosterone and stimulates the nervous system. Infused with Maca, Damiana and Horny Goat Weed.
* Tranquility Blend - achieves anti-stress effect through reducing muscle tension and anxiety. Also improves concentration, enhances overall mood and eases pain by reducing the negative trigger endorphins which stimulates secretion of serotonin. Infused with Gaba Ashwagandha and Griffonia
* Energy Blend - increases energy, focus and awareness, includes antioxidants that invigorate the body and contains minerals, vitamins, proteins, fibers and essential fatty acids. Infused with Guarana, Acai, Gogi and Chocolate.
Apart from health benefits, the above Health and Wellness Coffee Lines are produced using Green manufacturing process and strictly following 100% Biodegradable packaging guidelines. All coffees are Fair Trade and certified Organic infused with 100% natural extracts with bio-altering properties, caffeine being used as a delivery method.
* CBD-infused Coffee
Coffee infused with CBD produces anti-stress effect as well as reduces aches and pains at the same time helping the user feel alert, calm and focused. Can have three levels of strength - intro, regular and maximum.
Product is manufactured using 100% Specialty grade coffee beans and organically grown hemp extracts.
Coffee is roasted and infused in an FDA registered facility in compliance with industry-standard good
manufacturing practices (GMP).
Can come in forms of whole bean, roast and ground, K-cup and Nespresso compatible pods.
On March 11, 2022 Megola entered into a Purchase and Sale of Business Assets Contract with Medesol LLC
On March 11, 2022, MGON entered into a Purchase and Sale of Business Assets Contract with Medesol LLC, (www.sio2international.com, www.medesolglobal.com ) in which MGON has agreed to purchase license and manufacturing rights to Sio2 Proteksol for Seed & Foliage that is a safe, nano-particle free, water based, environmentally friendly coating application that assists the seeds, plants natural ability to grow, for the purchase price of Fifteen Thousand Dollars ($15,000), payable as follows: (1) fifteen thousand (15,000) shares of MGON Series F Preferred Stock, valued at $1.00 per share.
Easy to apply, SIO2 Proteksol Seed & Foliage coating is VOC free and treats the seed with a coating of safe silicon dioxide molecules - the same molecules found in the seed itself. The coating encapsulates the seed in a protective barrier that prevents mold and mildew issues and acts as a fertilizer to assist in its growth.
With an array of different seed types, SIO2 Proteksol Seed & Foliage:
• increases germination,
• enhances root size,
• increases shoot length by more than 60%,
• expedites cotyledon growth,
• increases seed vigor,
• increases yield per acre. These benefits mean that treated seeds germinate faster, less are lost due to mold/mildew and plants grow quicker.
The use of SIO2 Proteksol Seed & Foliage coating will eliminate the need for traditional chemical fertilizers that are ineffective due to hydrolysis, decomposition, degradation due to photosynthesis, expensive and can leach into the soil causing further issues. SIO2 Proteksol Seed & Foliage coating acts as an individual super fertilizer that targets each individual seed without waste and protects it against the caustic nature of soil.
For more information on Megola brands: http://megolacorp.com
For more information on Balanced2Day: Balanced2Day.com
For more information on The Stink Genie: GenieBrands.com
For more information on Medesol Global: www.sio2international.com,
www.medesolglobal.com
For more information Contact:
Megola, Inc.
Attn: John MacLeod
http://megolacorp.com
http://twitter.com/megolacorp
megola2020@gmail.com
1-888-587-1698
Stock information here: https://www.otcmarkets.com/stock/MGON/overview
Disclaimer: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement.
SOURCE: Megola, Inc.
View source version on accesswire.com:
https://www.accesswire.com/692844/Megola-Confirms-2-Acquisition-Product-Lines
$KOSK Harrison, NY., March 03, 2022 (GLOBE NEWSWIRE) -- One Step Vending Corp. (OTC: KOSK) (“KOSK” or “the Company”), a company specializing in emerging industries acquisitions with an emphasis in the self-serve vending market, announces updates on its ten vending machines shared late last year after entering into a joint venture letter of intent with Foundation Farms 2021, Corp..
https://www.stocktitan.net/news/KOSK/one-step-vending-corp-kosk-announces-updates-on-its-vending-machines-k9p8j06qst0t.html
$RBNW News: Lust for Life Footwear Meeting Strong Consumer Demand with On-Time Deliveries for Projected 50% Revenue Growth in Shipping Dollars for 2022
Click here:
https://www.accesswire.com/687881/Lust-for-Life-Footwear-Meeting-Strong-Consumer-Demand-with-On-Time-Deliveries-for-Projected-50-Revenue-Growth-in-Shipping-Dollars-for-2022-New-Product-Lines-to-Include-Mens-Styles-for-the-First-Time-to-Significantly-Expand-Market-Share-Penetration
Renewable Energy & Power, Inc. (OTC PINK:RBNW) is the parent company to Lust for Life Group. RBNW is a holding company for apparel lines with both direct to consumer and wholesale sales to national retail chains. Previously, RBNW was focused on renewable energy projects, however in August 2019, with the acquisition of Blind Faith Concepts, Inc., which holds 100% of Lust for Life, LLC, RBNW's management determined to shift operations to focus on apparel. For more information on RBNW, visit http://www.lustforlifeshoes.com.
$TPII News: Independent Test of GenSet shows 90% Fuel Savings
Better than Expected Test Results
Conducted by Frontier Power Products in Canada, independent testing of the company's EEL Diesel Hybrid Genset showed it could consistently sustain the test load for 16 hours from only one hour of diesel operation. The test load was representative of a typical load in many of the envisaged remote applications for the EEL Diesel Hybrid Genset.
Commenting on the test results, company CEO Murray Goldenberg stated, "We're extremely pleased with the outcomes of Frontier's testing. Our original estimates were that the unit would be capable of 12 hours of sustained operation from one hour of diesel operation. That it was able to achieve 16 hours came as a surprise to everyone, and has led us to increase our combined fuel and maintenance cost saving estimates up to 90% when compared to a standard diesel genset."
https://www.otcmarkets.com/stock/TPII/news/Results-Show-Unit-Able-to-Deliver-Combined-Fuel-and-Maintenance-Cost-Savings-of-90?id=343811
z
$GTCH Cheatsheet https://www.barchart.com/stocks/quotes/GTCH/cheat-sheet
$AVCO News: Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapies
Leveraging Avalon’s existing Flash-CARTM technology platform to develop next-generation mRNA-based CAR-NK cellular therapeutics
Clinical development of CAR-NK cell therapy planned in collaboration with the Company’s clinical partner, Lu Daopei Hospital, as a potential treatment for hematologic malignancies and other unmet medical areas
Appoints Dongfang Liu, Ph.D., a world-class scientist and expert in CAR-NK technology, to Avalon’s Scientific and Clinical Advisory Board
FREEHOLD, N.J., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies and therapeutics, announced today that the Company is expanding its cellular immuno-oncology program with the addition of novel Chimeric Antigen Receptor – Natural Killer (CAR-NK) cell therapies.
Natural killer (NK) cells constitute an important component of the immune system. NK cells seek out abnormal cells, including cancerous cells, and destroy them. However, cancer cells are often capable of “masking” themselves to evade attack by NK cells. By adding a “Chimeric Antigen Receptor” (CAR) to a patient’s own or universal-donor NK cells, these engineered CAR-NK cells are designed to “unmask,” recognize and destroy a patient’s specific tumor surface targets.
Avalon is leveraging its mRNA-based FLASH-CAR™ platform to develop autologous and universal (“off-the-shelf”) CAR-NK technology and cellular therapies for the potential treatment of hematologic malignancies and solid tumors. Avalon plans to expand its clinical program in collaboration with its major clinical trial partner, the Lu Daopei Hospital.
The new CAR-NK therapies in development are intended to build upon and complement AVA-011, Avalon’s lead CAR-T candidate, part of the Company’s proprietary mRNA-based FLASH-CAR™ platform. AVA-011 is currently at the IND-enabling, process development stage, which is expected to produce clinical-grade CAR-T cells for an upcoming clinical trial in patients with hematological malignancies. The platform uses next generation CAR technology to modify patients’ T or universal-donor NK cells using a ribonucleic acid (RNA)-based platform rather than a viral vector, allowing for more rapid and lower-cost bio-manufacturing of the cell therapy products.
To further strengthen its CAR-NK development capabilities, Avalon has appointed Dr. Dongfang Liu to its Scientific and Clinical Advisory Board. Dr. Liu is currently an Associate Professor and Director of Immunoassay Development Program at the Department of Pathology, Immunology and Laboratory Medicine at The Rutgers University New Jersey Medical School. Dr. Liu’s research expertise is focused on the immunobiology of NK and CAR-NK, with more than 20 years of experience in NK cell research. Dr. Liu is a prolific author in top-tier journals including Nature Immunology, Immunity, Nature Medicine, Nature Communications, JACI, and PNAS. Dr. Liu also serves on the editorial boards of several scientific journals and as a reviewer for scientific journals and grant agencies.
“CAR-NK represents a powerful and innovative tool in the fight against cancer, and we believe our mRNA-based FLASH-CAR™ platform will enable us to develop best-in-class therapies,” said David Jin, M.D., Ph.D., President and Chief Executive Officer of Avalon GloboCare. “We are especially pleased to welcome Dr. Dongfang Liu to our Scientific and Clinical Advisory Board. Dr. Liu will become an invaluable part of the team in expanding and supporting Avalon’s pipeline. We also appreciate the support of our world-class clinical partners, including the researchers and clinicians at the prestigious Lu Daopei Hospital, as we develop our cellular immuno-oncology programs for hematologic malignancies as well as other unmet medical needs,” added Dr. Jin.
About Avalon GloboCare Corp.
Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics. For more information about Avalon GloboCare, please visit http://www.avalon-globocare.com.
For the latest updates on Avalon GloboCare's developments, please follow our twitter at @avalongc_avco
Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.
Contact Information:
Avalon GloboCare Corp.
4400 Route 9, Suite 3100
Freehold, NJ 07728
PR@Avalon-GloboCare.com
Investor Relations:
Crescendo Communications, LLC
Tel: (212) 671-1020 Ext. 304
avco@crescendo-ir.com
https://www.globenewswire.com/newsroom/ti?nf=ODQ3NDQ4MyM0NzI1NTg4IzIxODQyMDc=
https://ml.globenewswire.com/media/ZDZiODk3MGMtNmM3Zi00NDU3LWFlODYtZWNmMjNlNTc5ZTY1LTExOTU3NjE=/tiny/Avalon-GloboCare-Corp-.png
Source: Avalon GloboCare Corp.
$CURR: Patented Oral Thin Film Drug Delivery Company Partnered with Star Nicole Kidman: CURE Pharmaceutical
Click here:
https://www.einnews.com/pr_news/561375441/patented-oral-thin-film-drug-delivery-company-partnered-with-star-nicole-kidman-cure-pharmaceutical-stock-symbol-curr
$NICH Nitches is producing and manufacturing this new brand in collaboration with Mr. Nick Cooper named "FutureMega". Nitches plans to rapidly expand and finish the year end with its coming lineup of celebrities and influencers launching in the beginning of 2021. With Mr. Cooper's long history in developing and producing for current stars, FutureMega is a movement focused on Gen-Z and the next generation.
$GTCH GBT GRANTED Patents (IP – Intellectual Property) Update
https://finance.yahoo.com/news/gbt-granted-patents-ip-intellectual-130000119.html?soc_src=social-sh&soc_trk=tw&tsrc=tw
Followers
|
838
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
48820
|
Created
|
04/12/12
|
Type
|
Free
|
Moderator logical cash | |||
Assistants bra1loga TechnoAnalyst The Bull Investment Group |
Posts Today
|
0
|
Posts (Total)
|
48820
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |